Issue of Equity

11 May 2009 16:21

Verona Pharma plc (the "Company") Issue of Equity

The Company announces that it has issued 223,030 new ordinary shares of 0.1p each in the Company ("Ordinary Shares") at 4.125p per share as consideration for pubic relations services provided to the Company. Application has been made for 223,030 Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 15 May 2009 ("Admission").

On Admission, the Company will have 215,481,355 shares in issue.

For further information please contact:

Professor Clive Page, Verona Pharma plc Tel: 07971 504 931

Adrian Kirk, WH Ireland Limited Tel: 0161 832 2174